REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 174 filers reported holding REATA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,126,997 | -1.8% | 109,131 | -12.4% | 0.03% | -12.5% |
| Q1 2023 | $11,326,814 | +105.0% | 124,580 | -14.3% | 0.03% | +88.2% |
| Q4 2022 | $5,525,418 | +357.0% | 145,444 | +202.3% | 0.02% | +325.0% |
| Q3 2022 | $1,209,000 | -55.1% | 48,115 | -52.8% | 0.00% | -33.3% |
| Q4 2021 | $2,690,000 | -63.9% | 102,002 | +97.4% | 0.01% | -90.2% |
| Q1 2020 | $7,460,000 | +261.4% | 51,682 | +114.0% | 0.06% | +771.4% |
| Q1 2019 | $2,064,000 | – | 24,147 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |